MEDICIS restarts its program today. Mass separation will be applied to purify and separate Sm-153 from a target produced at BR2. Some details on the project here.
World cancer day: webinar at 11:30 on MEDICIS mass separation and its impact on theranostics here.
The 1st call for user projects of PRISMAP is launched! More information here.
PRISMAP-The European medical radionuclides programme sets out to substantially change the European landscape for novel and emerging medical radionuclides. More information here.
A KNOWLEDGE TRANSFER SUCCESS STORY